We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+12.13%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.7B
AUM Growth
+$651M
(+2%)
Cap. Flow
-$2.75B
Cap. Flow
% of AUM
-8.41%
Top 10 Holdings %
Top 10 Hldgs %
20.41%
Holding
1,997
New
181
Increased
978
Reduced
793
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$146M |
| 2 |
Albemarle
ALB
|
+$38M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$32.7M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$30.8M |
| 5 |
J.M. Smucker
SJM
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$420M |
| 2 |
Microsoft
MSFT
|
+$382M |
| 3 |
Amazon
AMZN
|
+$209M |
| 4 |
NVIDIA
NVDA
|
+$163M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Industrials | 12.61% |
| 3 | Consumer Staples | 11.87% |
| 4 | Financials | 10.22% |
| 5 | Consumer Discretionary | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Keros Therapeutics
KROS
$199M
| $224K | ﹤0.01% |
+5,640
| New | +$177K |
|
1577
Kilroy Realty
KRC
$4.58B
| $224K | ﹤0.01% |
+5,612
| New | +$185K |
|
1578
ANI Pharmaceuticals
ANIP
$1.77B
| $223K | ﹤0.01% |
4,043
+472
| +13% | +$26K |
|
1579
DHT Holdings
DHT
$2.97B
| $223K | ﹤0.01% |
22,718
+4,890
| +27% | +$50.3K |
|
1580
Shutterstock
SSTK
$205M
| $223K | ﹤0.01% |
+4,615
| New | +$195K |
|
1581
Cannae Holdings
CNNE
$647M
| $222K | ﹤0.01% |
+11,371
| New | +$207K |
|
1582
LegalZoom.com
LZ
$1.23B
| $222K | ﹤0.01% |
19,622
+6,089
| +45% | +$66.3K |
|
1583
Encore Capital Group
ECPG
$1.93B
| $222K | ﹤0.01% |
+4,369
| New | +$198K |
|
|
ZUO
1584
DELISTED
Zuora, Inc.
ZUO
| $222K | ﹤0.01% |
23,586
+5,407
| +30% | +$44.6K |
|
1585
Wabash National
WNC
$543M
| $222K | ﹤0.01% |
+8,649
| New | +$195K |
|
1586
TriCo Bancshares
TCBK
$1.85B
| $221K | ﹤0.01% |
+5,146
| New | +$185K |
|
1587
National Beverage
FIZZ
$2.87B
| $221K | ﹤0.01% |
+4,443
| New | +$213K |
|
1588
MannKind Corp
MNKD
$1.28B
| $220K | ﹤0.01% |
60,395
+9,487
| +19% | +$36.2K |
|
|
DO
1589
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $219K | ﹤0.01% |
16,851
+3,626
| +27% | +$46.8K |
|
1590
Krispy Kreme
DNUT
$543M
| $219K | ﹤0.01% |
14,500
+3,120
| +27% | +$41.3K |
|
1591
National Healthcare
NHC
$3.53B
| $219K | ﹤0.01% |
+2,367
| New | +$181K |
|
1592
Xenon Pharmaceuticals
XENE
$6.32B
| $217K | ﹤0.01% |
+4,721
| New | +$167K |
|
1593
Envista
NVST
$4.28B
| $217K | ﹤0.01% |
9,016
+168
| +2% | +$4.01K |
|
1594
ACM Research
ACMR
$5.83B
| $216K | ﹤0.01% |
+11,058
| New | +$193K |
|
|
LADR
1595
Ladder Capital
LADR
$1.25B
| $216K | ﹤0.01% |
18,759
+4,037
| +27% | +$43K |
|
1596
Perdoceo Education
PRDO
$1.9B
| $216K | ﹤0.01% |
12,274
+2,080
| +20% | +$36.7K |
|
1597
SFL Corp
SFL
$1.59B
| $215K | ﹤0.01% |
19,070
+4,104
| +27% | +$45.7K |
|
1598
Zentalis Pharmaceuticals
ZNTL
$308M
| $215K | ﹤0.01% |
14,162
+1,979
| +16% | +$28.9K |
|
1599
Kforce
KFRC
$983M
| $214K | ﹤0.01% |
+3,174
| New | +$202K |
|
|
UDMY
1600
DELISTED
Udemy
UDMY
| $214K | ﹤0.01% |
14,556
+3,408
| +31% | +$42.4K |
|
Similar funds
ProShare Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, ProShare Advisors held 1,997 positions worth $32.7B, up 2% from $32.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors withdrew a net $2.75B in Q4 2023, closing 44 positions and reducing 793 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in DoorDash worth $28.6M.
- ProShare Advisors's largest Q4 2023 buy was DoorDash: 289,583 shares worth $28.6M.
- ProShare Advisors added most to Kenvue in Q4 2023, an estimated $146M increase.
- ProShare Advisors's biggest Q4 2023 reduction was Apple, cutting an estimated $420M.
- ProShare Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $40.1M.
- ProShare Advisors's ten largest holdings make up 20% of its $32.7B portfolio in Q4 2023.
- ProShare Advisors opened 181 new positions and closed 44 in Q4 2023.
- ProShare Advisors's portfolio value rose 2% quarter-over-quarter to $32.7B.
Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.